Liquid Biopsy Differentiation of Pancreatic Cancer From Non‐Cancerous Pancreatic Disease Using Dielectrophoresis‐Recovered Nanoparticles Carrying Cell‐Free DNA and Protein Biomarkers (Small 29/2026)

Pancreatic Cancer Detection Tumors release extracellular vesicle nanoparticles into circulation which carry important cancer-specific biomarkers. These nanoparticles are readily recovered from undiluted plasma by a microfluidic chip with an array of circular microelectrodes at the bottom that generate dielectrophoretic forces, represented by the curved vertical and horizontal lines. These forces enable on-chip nanoparticle recovery, purification, and biomarker quantification which has diagnostic value and can accurately detect patients with pancreatic cancer. More in the Research Article (e02532), Stuart D. Ibsen and co-workers.